Aarti Drugs Ltd. Financials

NSE BSE

15:58 Jul 18

Aarti Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

523.20

+5.40 (+1.04%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

523.20

+5.40 (+1.04%)
15:58 Jul 18

Quality

57/100
High Financial Strength

Valuation

48/100
Mid Valuation

Technical

63/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	2488.65	2716.05	2528.58	2387.03	2422.2
Operating Expenses +	2159.21	2410.46	2212.11	2099.97	2126.02
Raw Material	1774.93	1890.26	1652.21	1522.64	1543.18
Increase Decrease in Cost	-86.08	-1.75	25.51	19.46	12.51
Other Manufacturing Expense	295.98	334.09	346.28	0	0
Employee Cost	82.81	92.02	102.34	112.1	116.47
Miscellaneous Expenses	308.71	338.42	246.23	614.45	453.86
Operating Profit	329.44	305.59	316.47	287.06	296.18
Other Income	11.32	2.19	4.03	16.36	15.56
Depreciation	50.05	50.32	51.45	55.78	57.12
Interest	20.75	33.29	33.52	35.87	35.72
Profit before tax and exceptio..	269.96	224.18	235.53	211.77	218.9
Exceptional Items	0	0	0	0	0
PBT	269.96	224.18	235.53	211.77	218.9
Provision for Taxation	64.96	57.82	63.94	43.67	30.11
Net Profit	205	166.36	171.59	168.1	188.79
NET Profit after MI	205.04	166.31	171.42	168.16	188.83
EPS	22.12	17.97	18.56	18.35	20.68
Operating Profit Margin (%)	13.24	11.25	12.52	12.03	12.23
Net Profit Margin (%)	8.24	6.12	6.78	7.04	7.8

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	55.20	55.50	55.40	55.60	55.70
FII	2.30	2.20	2.30	2.50	3.00
MF	9.80	8.80	7.80	6.20	5.70
Others	0.10	0.90	0.90	1.60	1.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: